Tag Archives: biotechnology

Genetic Engineering Makes the Blacklist

Posted on April 16, 2015 by Warren Woessner

James Spader was quirkily funny as Denny Crane’s partner on “Boston Legal,” but NBC’s “The Blacklist” has him operating totally outside of the law. He plays Raymond Reddington, an enigmatic figure who reveals to a black-ops FBI agent the evil … Continue reading →

Posted in Miscellaneous | Tagged bioluminescence, biotechnology, biotechnology law, genetic engineering, intellectual property, ip, James Spader, jellyfish, Smithsonian, The Blacklist, Warren Woessner | Leave a comment

Enzo Biochem V. Applera Corp. – When “Words Can Hurt You”

Posted on March 19, 2015 by Warren Woessner

On March 16, 2015 (Appeal no. 2014-1321), the Fed. Cir. reversed the district court’s construction of a claim term relating to the scope of “A,” a moiety capable of direct or indirect signaling that is attached by a linker to … Continue reading →

Posted in Patent Eligible Subject Matter | Tagged Applera Corp, biotechnology, biotechnology law, Enzo Biochem, Federal Circuit, intellectual property, ip, Warren Woessner | Leave a comment

Novartis Wins Landmark Biosimilar Approval

Posted on March 9, 2015 by Warren Woessner

Novartis Navigates The FDA-ACA Maze – Gets Approval For Generic Neuprogen. Amgen will soon find itself in a price war with Sandoz – a Novartis company – as it tries to maintain its share of the market for Neuprogen (filgraslim). … Continue reading →

Posted in Patent Eligible Subject Matter | Tagged Amgen, biotechnology, Federal Circuit, intellectual property, ip, Neuprogen, Novartis, Sandoz, Warren Woessner | Leave a comment

Patents4Life is Six Years Old this Month. Happy Birthday to Us!

Posted on March 3, 2015 by Warren Woessner

Six years ago, In re Kubin caused a flurry of concern among biotech practitioners, and a short article on this decision was the first post on Patents4Life. That was a pretty big “story” at the time but we all had … Continue reading →